盆底磁刺激联合坦索罗辛治疗良性前列腺增生症术后下尿路症状的疗效观察

Clinical Observation on the Efficacy of Pelvic Floor Magnetic Stimulation Combined with Tamsulosin in the Treatment of Lower Urinary Tract Symptoms after Benign Prostatic Hyperplasia Surgery

摘要: 目的：观察盆底磁刺激联合坦索罗辛在治疗良性前列腺增生症术后下尿路症状的临床效果。方法：以2025年1月至2026年1月为研究时间段，期间共收集100例良性前列腺增生症术后出现下尿路症状患者。根据不同治疗方法对研究样本进行分组，50例单一使用坦索罗辛进行治疗，分入对照组。另外50例患者叠加盆底磁刺激治疗，纳入观察组。并在前列腺症状评分、生活质量评分、残余尿量、排尿次数以及不良反应发生率方面进行比较。结果：经过治疗后，观察组患者各项评分、残余尿量、排尿次数和对照组患者相比均较低(P < 0.05)；两组患者不良反应发生率比较无差异(P > 0.05)。结论：为良性前列腺增生症术后出现下尿路症状患者在使用坦索罗辛治疗的基础上叠加盆底磁刺激质量能够显著改善患者症状，提升生活质量。同时，在治疗安全性方面有一定的保障。

Abstract: Objective: To observe the clinical efficacy of pelvic floor magnetic stimulation combined with tamsulosin in the treatment of lower urinary tract symptoms (LUTS) after surgery for benign prostatic hyperplasia (BPH). Methods: A total of 100 patients with lower urinary tract symptoms after BPH surgery were enrolled from January 2025 to January 2026. They were divided into two groups according to different treatment methods: 50 patients treated with tamsulosin alone were assigned to the control group, and another 50 patients treated with additional pelvic floor magnetic stimulation were included in the observation group. The International Prostate Symptom Score (IPSS), quality of life score (QoL), post-void residual urine volume, frequency of urination, and incidence of adverse reactions were compared between the two groups. Results: After treatment, all scores, post-void residual urine volume, and frequency of urination in the observation group were significantly lower than those in the control group (P < 0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P > 0.05). Conclusion: For patients with lower urinary tract symptoms after BPH surgery, the addition of pelvic floor magnetic stimulation on the basis of tamsulosin can significantly improve clinical symptoms and quality of life, with favorable treatment safety.